6879.TWO
Price:
$37.2
Market Cap:
$984.26M
TCI GENE Inc. provides precision preventive medicines in Taiwan. It offers genetic testing for nutrient metabolism and weight management; G2 and ACE2 genetic testing; supplements; skin care, antiaging, kids' growth, and Alzheimer disease products; and serum for DNA types. The company also provides nutrition consultation services. TCI GENE Inc. is based in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2022-05-26
Stock Exchange
TWO
Ticker
6879.TWO
According to TCI GENE Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.74. This represents a change of -22.37% compared to the average of 7.39 of the last 4 quarters.
The mean historical Current Ratio of TCI GENE Inc. over the last ten years is 4.95. The current 5.74 Current Ratio has changed 11.50% with respect to the historical average. Over the past ten years (40 quarters), 6879.TWO's Current Ratio was at its highest in in the December 2024 quarter at 9.82. The Current Ratio was at its lowest in in the June 2019 quarter at 0.
Average
4.95
Median
4.87
Minimum
0
Maximum
9.82
Discovering the peaks and valleys of TCI GENE Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 9.82
Minimum Annual Increase = -8.59%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 9.82 | 42.87% |
| 2023 | 6.87 | -8.59% |
| 2022 | 7.52 | 161.80% |
| 2021 | 2.87 | 9.80% |
| 2020 | 2.61 | Infinity% |
The current Current Ratio of TCI GENE Inc. (6879.TWO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
8.07
5-year avg
5.94
10-year avg
4.95
TCI GENE Inc.’s Current Ratio is greater than Level Biotechnology Inc. (1.63), less than LAUNXP Biomedical Co., Ltd (7.53), less than NatureWise Biotech & Medicals Corporation (11.89), less than Eusol Biotech Co.,Ltd. (43.56), less than Andros Pharmaceuticals Co.,Ltd (13.81), less than Bio Preventive Medicine Corp. (19.06), greater than Taiwan Advance Bio-Pharmaceutical Inc. (0.90), less than SynCore Biotechnology Co.,Ltd (11.18), greater than Lukas Biomedical Inc. (1.21), less than LabTurbo Biotech Corporation (14.89),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.63 | $1.08B | |
| 7.53 | $1.12B | |
| 11.89 | $1.04B | |
| 43.56 | $856.25M | |
| 13.81 | $1.26B | |
| 19.06 | $1.14B | |
| 0.90 | $1.05B | |
| 11.18 | $909.02M | |
| 1.21 | $1.33B | |
| 14.89 | $1.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TCI GENE Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TCI GENE Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is TCI GENE Inc.'s Current Ratio?
How is the Current Ratio calculated for TCI GENE Inc. (6879.TWO)?
What is the highest Current Ratio for TCI GENE Inc. (6879.TWO)?
What is the 3-year average Current Ratio for TCI GENE Inc. (6879.TWO)?
What is the 5-year average Current Ratio for TCI GENE Inc. (6879.TWO)?
How does the current Current Ratio for TCI GENE Inc. (6879.TWO) compare to its historical average?